Will the abrdn share price keep falling?

Rupert Hargreaves explains why he thinks the abrdn share price may continue to struggle as profits remain under pressure.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Over the past three years, the performance of the abrdn (LSE: ABDN) share price has been incredibly disappointing. During this period, including dividends paid to investors, the stock has returned -0.6% a year.

By comparison, the FTSE All-Share Index has added 4.6% per annum, including dividends. To put it another way, the stock has underperformed the broader market by 5.2% per annum since October 2018.

Over the past 12 months, its performance has been marginally better, but not by much. In the past year, the stock has returned 5.2%, compared to a gain of 24% for the FTSE All-Share. 

As a value investor, I’m always drawn to stocks that are underperforming the market, as this can be a sign they may be undervalued. With that being the case, I have been taking a closer look at the company, which was formerly known as Standard Life Aberdeen, to see if it could be worth adding the stock to my portfolio as a value investment. 

abrdn share price outlook 

Whenever I stumble across a company that’s underperformed the market, I always try to understand why investors have been giving the business the cold shoulder before I take a position. 

abrdn has been struggling to attract investors for years. Even the company’s name change hasn’t ignited investor interest. It seems as if there are a couple of reasons why. The asset management group has been struggling to retain customers. Assets under management (AUM) have declined year after year. AUM declined a further 1% during the first half of 2021. 

What’s more, the group’s desirable dividend yield, which currently stands at 5.8%, isn’t covered by profits. The company has been digging into its reserves to fund the payout. 

Still, it has plenty of liquidity. Management has been selling off the company’s stakes in overseas divisions HDFC and Parmenion. The group has also been selling its life insurance liabilities, and this has freed up capital. 

However, the fact remains that the firm is paying out more than it can afford to its investors, and customers are walking out the door.

This combination of factors seems to explain why the market has been pushing the abrdn share price lower. With more money flowing out than coming in, the business is technically shrinking. That means it will ultimately be worth less. 

Turn around on the horizon? 

Still, the group could be on the verge of a turnaround. Outflows are slowing, thanks in part to the fact that the majority of the investment funds managed by the group are outperforming their respective benchmarks. If this continues, outflows could reverse entirely. That would almost certainly have a positive impact on investor sentiment towards the abrdn share price. 

Further, management is still identifying cost savings from the Standard Life and Aberdeen Asset Management merger. These synergies could help improve the group’s profit margins and dividend sustainability. 

Considering these factors, I’m cautiously optimistic about the outlook for the abrdn share price. If it can reverse outflows and boost profitability, I think the stock can change course. However, until there’s some concrete progress, I won’t be buying the shares for my portfolio.

I’d rather wait on the sidelines until the firm starts to reverse course. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »